Thomassen Yvonne E, Rubingh Olaf, Wijffels René H, van der Pol Leo A, Bakker Wilfried A M
Institute for Translational Vaccinology, Process Development, PO BOX 450, Bilthoven 3720 AL, The Netherlands.
Wageningen University, Bioprocess Engineering, PO BOX 8129, Wageningen 6700 EV, The Netherlands.
Vaccine. 2014 May 19;32(24):2782-8. doi: 10.1016/j.vaccine.2014.02.022. Epub 2014 Feb 26.
Vero cells were grown adherent to microcarriers (Cytodex 1; 3 g L(-1)) using animal component free media in stirred-tank type bioreactors. Different strategies for media refreshment, daily media replacement (semi-batch), continuous media replacement (perfusion) and recirculation of media, were compared with batch cultivation. Cell densities increased using a feed strategy from 1×10(6) cells mL(-1) during batch cultivation to 1.8, 2.7 and 5.0×10(6) cells mL(-1) during semi-batch, perfusion and recirculation, respectively. The effects of these different cell culture strategies on subsequent poliovirus production were investigated. Increased cell densities allowed up to 3 times higher D-antigen levels when compared with that obtained from batch-wise Vero cell culture. However, the cell specific D-antigen production was lower when cells were infected at higher cell densities. This cell density effect is in good agreement with observations for different cell lines and virus types. From the evaluated alternative culture methods, application of a semi-batch mode of operations allowed the highest cell specific D-antigen production. The increased product yields that can easily be reached using these higher cell density cultivation methods, showed the possibility for better use of bioreactor capacity for the manufacturing of polio vaccines to ultimately reduce vaccine cost per dose. Further, the use of animal-component-free cell- and virus culture media shows opportunities for modernization of human viral vaccine manufacturing.
Vero细胞在搅拌罐式生物反应器中,使用无动物成分培养基,贴壁生长于微载体(Cytodex 1;3 g L(-1))上。将不同的培养基更新策略,即每日更换培养基(半连续培养)、连续更换培养基(灌注培养)和培养基再循环,与分批培养进行了比较。采用补料策略时,细胞密度从分批培养期间的1×10(6) 个细胞/mL分别增加到半连续培养、灌注培养和再循环培养期间的1.8×10(6)、2.7×10(6) 和5.0×10(6) 个细胞/mL。研究了这些不同细胞培养策略对后续脊髓灰质炎病毒生产的影响。与分批培养的Vero细胞培养相比,细胞密度增加使得D抗原水平提高了3倍。然而,在较高细胞密度下感染细胞时,细胞特异性D抗原产量较低。这种细胞密度效应与不同细胞系和病毒类型的观察结果高度一致。在所评估的替代培养方法中,采用半连续操作模式可实现最高的细胞特异性D抗原产量。使用这些更高细胞密度培养方法能够轻松提高产品产量,这表明有可能更好地利用生物反应器产能来生产脊髓灰质炎疫苗,最终降低每剂疫苗的成本。此外,使用无动物成分的细胞和病毒培养基为人类病毒疫苗生产的现代化提供了机遇。